SCHEMBL21783533

SCHEMBL21783533

Cc1nc(SNc2cscn2)ccc1NCc1c(F)cccc1CN

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 20/20 0.53
SCN1A P35498 19/20 0.53
SCN5A Q14524 15/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783453 0.86 SCN1A (0.49) SCN8ASCN1ASCN5A
SCHEMBL21783328 0.86 SCN1A (0.70) SCN8ASCN1ASCN5A
SCHEMBL21783335 0.86 SCN8A (0.69) SCN8ASCN1ASCN5A
SCHEMBL21783422 0.85 SCN1A (0.71) SCN8ASCN1ASCN5A
SCHEMBL21783357 0.84 SCN1A (0.71) SCN8ASCN1ASCN5A
SCHEMBL21783361 0.83 SCN1A (0.71) SCN8ASCN1ASCN5A
SCHEMBL21783514 0.83 SCN1A (0.72) SCN8ASCN1ASCN5A
SCHEMBL22005469 0.80 SCN1A (0.80) SCN8ASCN1ASCN5A
SCHEMBL21783526 0.76 SCN1A (0.67) SCN8ASCN1ASCN5A
SCHEMBL22005526 0.76 SCN1A (0.79) SCN8ASCN1ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed